IVI Middle East Fertilty Clinic
Abu Dhabi, United Arab Emirates
NCT Number: NCT03519776
to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering.
Looking for future studies?
Notify Me18 year–45 year
Female
Observational
Abu Dhabi, United Arab Emirates
The impact of the progesterone level at the end of the follicular phase in stimulated IVF/ICSI cycles and its effect on the pregnancy rate and oocyte quality is controversial, which arises from conflicting results in retrospective studies and meta-analyses. This study is assumed to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering. If variation is present, the impact of variation on the developing oocyte and embryo quality will be estimated by embryo quality indicators.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The potential gain for medical caretakers and patients would be a certainty if the progesterone level is affected by variations during daytime
Time frame: 6-8 months
the circadian secretion-pattern of progesterone during early follicular phase of normal cycling females
ART Fertility Clinics LLC
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03930212
Abortion, Threatened, Female Urogenital Diseases and Pregnancy Complications
Tanta, Egypt
View Trial DetailsNCT05062135
Adnexal Diseases, Cysts
View Trial DetailsNCT03356964
Progesterone Resistance
Abu Dhabi, United Arab Emirates
View Trial DetailsNCT05316935
Atypical Endometrial Hyperplasia, Endometrial Hyperplasia
Shanghai, Shanghai Municipality, China
View Trial Details